Report post

Who owns Ars Pharmaceuticals Inc?

Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA. SPRY | Complete ARS Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Is Ars pharmaceuticals (Spry) a good stock to buy?

ARS Pharmaceuticals, Inc. (SPRY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. Financial Position: Ended the year with $228.4 million in cash, cash equivalents, and short-term investments.

What are Ars pharmaceuticals' share price targets?

4 analysts have issued 12-month price targets for ARS Pharmaceuticals' shares. Their SPRY share price targets range from $18.00 to $19.00. On average, they expect the company's share price to reach $18.50 in the next year. This suggests a possible upside of 104.2% from the stock's current price.

The World's Leading Crypto Trading Platform

Get my welcome gifts